Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioDiscovery Initiates Software Donation Program to Benefit Pediatric Research

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Company to donate up to $100,000 worth of software licenses per year to eligible scientists working in pediatric research.

BioDiscovery, Inc. has recently launched a new software donation program to assist scientists and benefit pediatric research.

The program is aimed towards those researchers with limited resources but promising projects that will advance diagnosis and treatment of pediatric diseases.

BioDiscovery provides software solutions and services for DNA copy number, gene and miRNA expression, and methylation analysis from microarray and next-generation sequencing (NGS) technologies.

“We are really excited to be able to fund this new program to assist promising young scientists make advances in pediatric research,” said Dr. Soheil Shams, President of BioDiscovery, Inc.

Dr. Shams continued, “We know there are brilliant researchers especially those just starting their careers who have great ideas and projects but may not yet have the funds to move forward with their research. We recognize the heartache children and their families face when afflicted with a disease. Many disorders don’t have any treatment options and some cannot even be diagnosed. We believe that limitations on funding should not be an impediment in finding better treatments, especially for pediatric maladies.”

BioDiscovery has allocated $100,000 worth of software licenses per year that it will be donating to eligible researchers working on pediatric diseases.

Those interested can view the requirements and fill out the application form on the BioDiscovery website. BioDiscovery’s software solutions are designed for the end-user scientist for visualization and analysis of genomic data from aCGH, SNP, methylation and gene/miRNA expression microarrays as well as from NGS technologies.

BioDiscovery’s software is platform independent and available for Mac OS X, Linux and Windows operating systems. BioDiscovery Nexus Copy Number is the leading platform independent and user friendly application for DNA copy number analysis.

Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, Next-Gen read depth, as well as custom arrays.

With its free access to a web-based repository for querying, and storing genomic data from any location across the globe, Nexus Copy Number is a powerful solution for large groups such as special consortia and collaborative research networks.

Nexus Expression is a complete package for analysis and visualization of gene and microRNA expression array data to identify differentially regulated probes, cluster samples and probes and identify common biological themes through gene set enrichment.

ImaGene is recognized by industry experts as the most complete solution for array image analysis with the highest quality results and the easiest to use microarray analysis user interface.

With single click automation, integrated advanced quality control parameters, numerous patented segmentation and contamination removal algorithms, and hundreds of active customers worldwide, ImaGene remains the leader in microarray image analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDiscovery Awarded National Institutes of Health SBIR Grant
SBIR Phase I grant to improve the copy number variation data from TCGA.
Thursday, July 10, 2014
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
Wednesday, February 11, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!